Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
5475032
Publication Date
12-12-1995
Abstract
2,4-disulfonyl α-phenyl-tert-butyl nitrone and its pharmaceutically acceptable salts are disclosed. These materials are useful as pharmaceutical agents for oral or parenteral, e.g. intravenous administration to patients suffering from acute central nervous system oxidation as occurs in a stroke or from gradual central nervous system oxidation which can exhibit itself as progressive central nervous system function loss. The materials are also used to ameliorate the side effects of oxidative-damage causing antineoplastic disease treatments.
Assignees
Oklahoma Medical Research Foundation, Oklahoma City, Okla., University of Kentucky Research Foundation, Lexington, Ky.
Application Number
426,961
Filing Date
04/24/1995
Recommended Citation
Carney, John M., "2,4-Disulfonyl Phenyl Butyl Nitrone, Its Salt and Their Use as Pharmaceuticals" (1995). Pharmacology and Nutritional Sciences Faculty Patents. 28.
https://uknowledge.uky.edu/pharmacol_patents/28
